Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
YesterdayDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
YesterdayRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
YesterdayThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
YesterdayBuffalo Potash Files Annual Information Form and New Technical Report
YesterdayIonik Announces 30-Day Extension of Senior Debt Facility
Xortx Therapeutics, Inc. logo

Xortx Therapeutics, Inc.

About

3.05CAD-0.06 -1.93%
Closed • Updated at 16:56 GMT+00:00
Market Cap$3.08M
Volume541
Beta-0.66
RSI45.07
Health TechnologyPharmaceuticals: Major

Xortx Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 19 2026
XORTX Announces Closing of US$5 Million Public Offering
May 18 2026
E.F. Hutton & Co. Serves as Exclusive Placement Agent on XORTX Therapeutics Inc. $5 Million Public Offering
May 14 2026
XORTX Announces US$5 Million Public Offering
Apr 21 2026
XORTX Meets Nasdaq Continued Listing Requirements
Apr 13 2026
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset

Community Chat

Ask AI

Try asking
6ix6ixAIEvents